Iolyx Therapeutics Announces Promising Phase II Results for ILYX-002 in Autoimmune Dry Eye Disease
ILYX-002 shows 3x greater corneal healing effect compared to current therapies on the market. Iolyx Therapeutics (California, United States), a…
New Swept-Source OCT Technique Shows Promise for In-Office Detection of Childhood Glaucoma
Hold the anesthesia—this baby-flying scan may spot glaucoma before nap time’s even over. A new imaging approach using swept-source anterior-segment…
popular posts
latest posts
